The Biomedical Engineer's Pledge

1) I will hold paramount the safety, health, and well-being of patients, research participants, coworkers, healthcare workers, and the public.

2) Upholding the above, I will exercise my profession with integrity and responsibility.

3) I will do my best to ensure the autonomy and dignity of patients and research participants.

4) I will ensure the proper safeguarding of patient and research participant data.

5) I will not discriminate on the grounds of age, sex, sexual orientation, gender identity or expression, disease, functional diversity, origin, racial status, religious beliefs, political affiliation, social class, or any other identity factors.

6) I will not participate in patient deception or fraud against them.

7) I will share my scientific and technical knowledge, and I will not use it to violate human rights.

8) I will promote the replacement, reduction, and refinement of the use of animals in research.

9) I will contribute to the environmental and economic sustainability of healthcare and to universal health coverage.

10) I will demonstrate to my teachers, colleagues of any discipline, students, and to the society at large, the respect and gratitude that is their due.

About Us

Our interdisciplinary research team consists of facutly and students from Shanghai University, the University of Saskatchewan, Shanghai Advanced Research Institute, East China University of Science and Technology, and Donghua University. Together, we operate a dedicated joint laboratory focused on the deficiency of energy-based tumor ablation modalities in treating tumors in liver and lung and the clinical translation of these modalities to brain cancers.

Specifically, our research aims to investigate and overcome the limitations of energy-based tumor ablation modalities such as microwave ablation (MWA), irreversible electroporation (IRE), and laser ablation in a multi-scale manner. Through the application of knowledge in artificial intelligence, mechanical engineering, tissue engineering, microfluidics, and cell biology, we seek to understand the underlying mechanisms that contribute to these limitations and design innovative precision ablation devices and/or protocols to overcome them. Our research is conducted through a range of methods, including in silico, ex vivo, in vitro, and in vivo experiments.

As a group, we are particularly interested in transnational research and welcome collaboration with other research institutes both locally and internationally to advance our understanding of energy-based tumor ablation and develop more effective and safe treatment modalities for cancer patients.